Search results
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
TipRanks via Yahoo Finance· 2 days agoRegeneron (NASDAQ:REGN) stock has more than tripled in value in the past five years, with the price...
JPMorgan Chase & Co. Raises Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $1,150.00
ETF DAILY NEWS· 4 days agoRegeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target raised by JPMorgan Chase & Co. from $1,050.00 to $1,150.00 in a report issued on Monday, Benzinga ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Integrated Advisors Network LLC
ETF DAILY NEWS· 2 days agoIntegrated Advisors Network LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.2% during the fourth quarter, according to the company ...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 4 days agoBiotech giant Regeneron Pharmaceuticals REGN is one of the few top biotech companies that has...
Regeneron director Brown sells shares worth over $1.5 million By Investing.com
Investing.com· 5 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) Director Michael S. Brown has completed...
Nvidia's One-Day Loss Exceeds The Value Of 85% Of The S&P 500
Investor's Business Daily· 22 hours agoThink you had a bad day? It's nothing compared to the drop Thursday by S&P 500 stock Nvidia. Shares...
Teachers Retirement System of The State of Kentucky Sells 1,245 Shares of Regeneron Pharmaceuticals,...
ETF DAILY NEWS· 6 days agoTeachers Retirement System of The State of Kentucky cut its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.7% during the 4th quarter, according ...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 5 days agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
Diana Taurasi Urges Patience With Caitlin Clark, WNBA Rookie Class
US Weekly· 4 days agoTaurasi, 42 — who spoke to Us Weekly to discuss her partnership with with Sanofi and Regeneron —...
Teva and DOJ May Reach Settlement in Closely Watched AKS Lawsuit
The National Law Review· 18 hours agoOn June 16, Teva Pharmaceuticals filed a request with the First Circuit Court of Appeals seeking to...